- Home
- DHX vs KYTX Comparison
DHX vs KYTX Comparison
Compare DHX & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHX
- KYTX
- Stock Information
- Founded
- DHX 1991
- KYTX 2018
- Country
- DHX United States
- KYTX United States
- Employees
- DHX N/A
- KYTX N/A
- Industry
- DHX Business Services
- KYTX
- Sector
- DHX Consumer Discretionary
- KYTX
- Exchange
- DHX Nasdaq
- KYTX NYSE
- Market Cap
- DHX 136.8M
- KYTX 130.8M
- IPO Year
- DHX 2007
- KYTX 2024
- Fundamental
- Price
- DHX $2.62
- KYTX $2.78
- Analyst Decision
- DHX Strong Buy
- KYTX Buy
- Analyst Count
- DHX 2
- KYTX 5
- Target Price
- DHX $5.25
- KYTX $23.20
- AVG Volume (30 Days)
- DHX 231.4K
- KYTX 468.8K
- Earning Date
- DHX 02-05-2025
- KYTX 03-04-2025
- Dividend Yield
- DHX N/A
- KYTX N/A
- EPS Growth
- DHX N/A
- KYTX N/A
- EPS
- DHX 0.01
- KYTX N/A
- Revenue
- DHX $141,926,000.00
- KYTX N/A
- Revenue This Year
- DHX N/A
- KYTX N/A
- Revenue Next Year
- DHX $1.64
- KYTX N/A
- P/E Ratio
- DHX $462.41
- KYTX N/A
- Revenue Growth
- DHX N/A
- KYTX N/A
- 52 Week Low
- DHX $1.45
- KYTX $2.65
- 52 Week High
- DHX $3.32
- KYTX $30.60
- Technical
- Relative Strength Index (RSI)
- DHX 47.12
- KYTX 36.42
- Support Level
- DHX $2.92
- KYTX $2.65
- Resistance Level
- DHX $3.32
- KYTX $3.11
- Average True Range (ATR)
- DHX 0.26
- KYTX 0.22
- MACD
- DHX -0.06
- KYTX 0.01
- Stochastic Oscillator
- DHX 15.66
- KYTX 17.88
About DHX DHI Group Inc.
DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and ClearanceJobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on our websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.